DNA
Ginkgo Bioworks Holdings
8.60$
-8.4%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Income Statement
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.14 | 0.69 | 0.76 | 1.09 | 1.70 | 0.84 | 0.89 | 0.90 | 0.70 | 0.60 | 0.33 | 0.32 | 1.80 | |
| 0.14 | 0.13 | 0.18 | 0.27 | 0.19 | 0.19 | 0.22 | 0.27 | 0.23 | -0.15 | 0.27 | 0.03 | 0.36 | |
| 0.99 | 0.56 | 0.57 | 0.83 | 1.51 | 0.66 | 0.67 | 0.63 | 0.47 | 0.75 | 0.06 | 0.30 | 1.44 | |
| 3.21 | 2.34 | 2.73 | 2.61 | 1.47 | 1.47 | 1.31 | 0.97 | 1.25 | 0.90 | 0.84 | 0.74 | 3.47 | |
| 1.68 | 1.78 | 1.41 | 1.29 | 1.00 | 1.10 | 0.90 | 0.79 | 0.81 | 0.83 | 0.64 | 0.50 | 2.57 | |
| 6.87 | 4.12 | 4.14 | 5.17 | 2.57 | 2.66 | 2.31 | 1.83 | 2.09 | 2.02 | 1.26 | 1.24 | 6.12 | |
| -5.87 | -3.56 | -3.56 | -4.34 | -1.06 | -2.00 | -1.64 | -1.19 | -1.62 | -1.28 | -1.20 | -0.94 | -4.68 | |
| – | 0.00 | – | – | – | 0.00 | – | – | – | – | – | – | – | |
| -6.21 | -4.24 | -3.32 | -4.22 | -1.09 | -2.08 | -1.68 | -1.10 | -1.45 | -1.47 | -1.28 | -0.92 | -4.76 | |
| 0.00 | 0.00 | 0.00 | 0.00 | -0.01 | -0.01 | 0.00 | -0.01 | 0.00 | -0.01 | 0.00 | 0.00 | -0.01 | |
| -6.21 | -4.23 | -3.32 | -4.23 | -1.08 | -2.07 | -1.68 | -1.10 | -1.45 | -1.46 | -1.39 | -0.75 | -4.68 | |
| -3.47 | -5.77 | -3.06 | -2.74 | -0.67 | -2.76 | -1.26 | -0.84 | -1.20 | -0.63 | -1.06 | -0.71 | -3.37 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.